| |
| Issue |
Title |
| |
| Vol 12, No 5 (2020) |
Recommendations for switching patients with highly active multiple sclerosis from other disease modifying drugs for multiple sclerosis to cladribine tablets |
Abstract
PDF (Rus)
|
|
N. A. Totolyan, V. M. Alifirova, K. Z. Bakhtiyarova, A. N. Boyko, Ya. V. Vlasov, Z. A. Goncharova, M. N. Zakharova, D. S. Kasatkin, S. V. Kotov, A. I. Nilov, S. A. Sivertseva, A. A. Sokolova, N. N. Spirin, F. A. Khabirov, D. Paradnika |
| |
| Vol 12, No 3 (2020) |
Recommendations for the use of cladribine tablets for the pathogenetic treatment of patients with highly active multiple sclerosis |
Abstract
PDF (Rus)
|
|
K. Z. Bakhtiyarova, A. N. Boyko, Ya. V. Vlasov, Z. A. Goncharova, M. V. Davydovskaya, M. N. Zakharova, N. A. Malkova, A. I. Nilov, S. A. Sivertseva, N. N. Spirin, N. A. Totolyan, F. A. Khabirov, M. V. Shumilina |
| |
| Vol 11, No 4 (2019) |
Current requirements for studies of drugs for the pathogenetic treatment of multiple sclerosis |
Abstract
PDF (Rus)
|
|
A. N. Boyko, N. N. Spirin, Ya. V. Vlasov, M. N. Zakharova |
| |
| Vol 7, No 3 (2015) |
Experience in using levodopa-benserazide |
Abstract
PDF (Rus)
|
|
Elena Anatolyevna Katunina, Yu. N. Bezdolnyi, E. A. Malykhina, N. V. Titova |
| |
| Vol 3, No 3 (2011) |
Treatment for poststroke spasticity, the use of mydocalm |
Abstract
PDF (Rus)
|
|
V. A. Parfenov |
| |
| Vol 3, No 3 (2011) |
Some aspects of the pathogenesis and treatment of back pain |
Abstract
PDF (Rus)
|
|
A. N. Barinov |
| |
| Vol 3, No 3 (2011) |
Cervicogenic headache: pathogenesis, clinical features, diagnosis, therapeutic approaches |
Abstract
PDF (Rus)
|
|
M. V. Putilina |
| |
| Vol 3, No 3 (2011) |
Neuroprotective therapy for chronic cerebral ischemia and ischemic stroke in the rehabilitation period; use of cavinton |
Abstract
PDF (Rus)
|
|
S. A. Rumyantseva, O. A. Sokhova, E. V. Silina |
| |
| Vol 3, No 2 (2011) |
Use of cereton in neurological care |
Abstract
PDF (Rus)
|
|
Yu. A. Starchina |
| |
| Vol 3, No 2 (2011) |
Role of melatonin in the treatment of depression |
Abstract
PDF (Rus)
|
|
O. V. Kotova |
| |
| Vol 3, No 1 (2011) |
Back pain is a reason to think about osteoporosis |
Abstract
PDF (Rus)
|
|
A. L. Vertkin, A. V. Naumov, S. R. Shakirova, D. M. Zaichenko, N. N. Vladimirova, E. V. Adonina |
| |
| Vol 2, No 4 (2010) |
Gastrointestinal events during treatment with nonsteroidal anti-inflammatory drugs (according to the data of the CONDOR study) |
Abstract
PDF (Rus)
|
|
V. V. Alekseev |
| |
| Vol 2, No 4 (2010) |
Osteoarthrosis or osteoarthritis? The name of the disease through the eyes of a practitioner |
Abstract
PDF (Rus)
|
|
N. A. Khitrov |
| |
| Vol 2, No 3 (2010) |
Treatment for spasticity after stroke |
Abstract
PDF (Rus)
|
|
S. E. Khatkova |
| |
| Vol 2, No 3 (2010) |
Chronic pain |
Abstract
PDF (Rus)
|
|
M. L. Kukushkin |
| |
| Vol 2, No 3 (2010) |
Insomnia: clinical experience with Zolpidem (Sanval) |
Abstract
PDF (Rus)
|
|
Ya. I. Levin |
| |
| Vol 2, No 2 (2010) |
Acetylsalicylic acid in the prevention and treatment of ischemic stroke |
Abstract
PDF (Rus)
|
|
A. V. Fonyakin |
| |
| Vol 2, No 2 (2010) |
Symptom modifiers in therapy for ankylosing spondylitis |
Abstract
PDF (Rus)
|
|
V. V. Badokin |
| |
| Vol 2, No 2 (2010) |
Antiaggregant therapy in neurological practice: objectives and possibilities |
Abstract
PDF (Rus)
|
|
E. V. Portnyagina, A. F. Portnyagin |
| |
| Vol 2, No 2 (2010) |
Possibilities of using Tanakan ® in therapy for generalized anxiety syndrome |
Abstract
PDF (Rus)
|
|
D. Yu. Veltishchev |
| |
| Vol 2, No 1 (2010) |
CERVICOGENIC HEADACHE: DIAGNOSIS AND TREATMENT |
Abstract
PDF (Rus)
|
|
A. N. Barinov |
| |
| Vol 2, No 1 (2010) |
THE POSSIBILITY OF USING NIMESULIDE IN NONSPECIFIC LOW BACK PAIN |
Abstract
PDF (Rus)
|
|
A. E. Karateev |
| |
| Vol 2, No 1 (2010) |
SUCCINIC ACID DERIVATIVES IN THERAPY FOR CEREBROVASCULAR DISEASE |
Abstract
PDF (Rus)
|
|
N. V. Pizova |
| |
| Vol 1, No 3-4 (2009) |
PHARMACOEPIDEMIOLOGICAL PARAMETERS OF USE OF POTENT OPIOIDS IN SAINT PETERSBURG (in the light of differences in approaches to using the drugs of this group in Russia and in the world) |
Abstract
PDF (Rus)
|
|
M. V. Pchelintsev, E. E. Zvartau, A. N. Kubynin |
| |
| Vol 1, No 3-4 (2009) |
PSYCHOPHARMOCOTHERAPY FOR PHOBIC AND OBSESSIVE-COMPULSIVE DISORDERS IN SCHIZOPHRENIA SPECTRUM STATES |
Abstract
PDF (Rus)
|
|
A. V. Pavlichenko, L. G. Kessel'man |
| |
| Vol 1, No 3-4 (2009) |
ANTITHROMBOCYTIC THERAPY IN THE SECONDARY PREVENTION OF ISCHEMIC STROKE |
Abstract
PDF (Rus)
|
|
A. V. Fonyakin, L. A. Geraskina |
| |
| Vol 1, No 3-4 (2009) |
ACETYLCALICYLIC ACID AND PREVENTION OF STROKE IN HIGH-RISK GROUP PATIENTS |
Abstract
PDF (Rus)
|
|
I. S. Yavelov |
| |
| Vol 1, No 3-4 (2009) |
CITICOLIN IN THE TREATMENT OF STROKE AND VASCULAR COGNITIVE DISORDERS |
Abstract
PDF (Rus)
|
|
V. A. Parfenov |
| |
| Vol 1, No 3-4 (2009) |
MILGAMMA AND MILGAMMA COMPOSITUM IN THE TREATMENT OF NEUROLOGICAL DISEASES |
Abstract
PDF (Rus)
|
|
N. V. Pizova |
| |
| Vol 1, No 3-4 (2009) |
COMPLEX THERAPY FOR HYPERTENSIVE AND MIXED ENCEPHALOPATHY |
Abstract
PDF (Rus)
|
|
S. A. Rumyantseva |
| |
| Vol 1, No 2 (2009) |
THE PROBLEMS OF THE PATHOGENESIS AND TREATMENT OF ALCOHOLIC POLYNEUROPATHY |
Abstract
PDF (Rus)
|
|
O. E. Zinov'eva, O. I. Angel'cheva |
| |
| Vol 1, No 2 (2009) |
METABOLIC CORRECTION OF NEUROLOGICAL COMPLICATIONS OF DIABETES MELLITUS |
Abstract
PDF (Rus)
|
|
S. A. Rumyantseva, V. A. Stupin, E. V. Silina, V. V. Mikhal'skiy, A. I. Perevedentsev, D. D. Ryzhova |
| |
| Vol 1, No 2 (2009) |
B-GROUP VITAMINS IN THE TREATMENT OF NERVOUS SYSTEM DISEASES |
Abstract
PDF (Rus)
|
|
Yu. A. Starchina |
| |
| Vol 1, No 1 (2009) |
THERAPY FOR EPILEPSY IN MIDDLE-AGED AND ELDERLY PATIENTS |
Abstract
PDF (Rus)
|
|
P. N. Vlasov, O. V. Andreeva |
| |
| Vol 1, No 1 (2009) |
Р-LIPOIC ACID PREPARATIONS IN THE TREATMENT OF DIABETIC NEUROPATHY |
Abstract
PDF (Rus)
|
|
O. E. Zinov'eva |
| |
| Vol 1, No 1 (2009) |
USE OF ACTOVEGIN IN NEUROLOGY |
Abstract
PDF (Rus)
|
|
Yu. A. Starchina |
| |
| 1 - 36 of 36 Items |
|
